NOISESaved copy
Coverage history

Assembled by NOISE.

Saved report copy

Recorded

CDC reportedly still plans to fund unethical hepatitis B trial

The CDC is still seeking to fund a suspended trial that would withhold hepatitis B birth doses from newborns in Guinea-Bissau, with staff in the director's office telling the budget office in late September to set aside $1.6 million, Rolling Stone reported. The grant would support Danish researchers Christine Stabell Benn and Peter Aaby in enrolling 14,000 newborns, giving half the birth dose and withholding it from half to look for alleged vaccine harms. Health experts and the World Health Organization call the design unethical because unvaccinated infants face high risk of chronic infection that can cause cirrhosis, liver cancer and premature death, and the study remains suspended pending authorization from Guinea-Bissau.